BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29348852)

  • 1. Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1.
    Ishii N; Araki K; Yokobori T; Gantumur D; Yamanaka T; Altan B; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Hosouchi Y; Kuwano H; Shirabe K
    Oncotarget; 2017 Dec; 8(68):112636-112646. PubMed ID: 29348852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer.
    Gasca J; Flores ML; Giráldez S; Ruiz-Borrego M; Tortolero M; Romero F; Japón MA; Sáez C
    Oncotarget; 2016 Aug; 7(33):52751-52765. PubMed ID: 27409838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXW7 mediates chemotherapeutic sensitivity and prognosis in NSCLCs.
    Yokobori T; Yokoyama Y; Mogi A; Endoh H; Altan B; Kosaka T; Yamaki E; Yajima T; Tomizawa K; Azuma Y; Onozato R; Miyazaki T; Tanaka S; Kuwano H
    Mol Cancer Res; 2014 Jan; 12(1):32-7. PubMed ID: 24165483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXW7 modulates malignant potential and cisplatin-induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1.
    Mori A; Masuda K; Ohtsuka H; Shijo M; Ariake K; Fukase K; Sakata N; Mizuma M; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Fujishima F; Unno M
    Cancer Sci; 2018 Dec; 109(12):3883-3895. PubMed ID: 30302867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
    Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
    Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
    Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Nie J; Lu L; Du C; Gao X
    Transl Cancer Res; 2022 Oct; 11(10):3790-3802. PubMed ID: 36388033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy.
    Ishii N; Araki K; Yokobori T; Watanabe A; Tsukagoshi M; Kubo N; Suzuki H; Saito F; Altan B; Hosouchi Y; Shirabe K; Kuwano H
    Oncol Lett; 2017 May; 13(5):3653-3661. PubMed ID: 28521468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of the ubiquitin ligase FBXW7 correlates with poor prognosis of patients with colorectal cancer.
    Liu H; Wang K; Fu H; Song J
    Int J Clin Exp Pathol; 2018; 11(1):413-419. PubMed ID: 31938126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
    Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
    Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
    He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z
    Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
    Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
    Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil-Targeting FBXW7 Tumor Suppressor.
    Fiore D; Piscopo C; Proto MC; Vasaturo M; Dal Piaz F; Fusco BM; Pagano C; Laezza C; Bifulco M; Gazzerro P
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
    Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
    Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7.
    Zhao J; Hu C; Chi J; Li J; Peng C; Yun X; Li D; Yu Y; Li Y; Gao M; Zheng X
    Oncol Rep; 2016 Aug; 36(2):1143-9. PubMed ID: 27350307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
    Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S
    Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity.
    Liu H; Li L; Chen H; Kong R; Pan S; Hu J; Wang Y; Li Y; Sun B
    Oncotarget; 2017 Sep; 8(37):61674-61686. PubMed ID: 28977895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
    Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
    Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases.
    Yokobori T; Mimori K; Iwatsuki M; Ishii H; Onoyama I; Fukagawa T; Kuwano H; Nakayama KI; Mori M
    Cancer Res; 2009 May; 69(9):3788-94. PubMed ID: 19366810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
    Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
    Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.